![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
M Gillner, J Bergman, C Cambillau, B Fernstrom and JA Gustafsson
In order to identify some of the structural requirements for binding of indoles to the receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), we have investigated the capacity of various indoles to inhibit specific [1,6-3H]TCDD binding in rat liver cytosol, as analyzed by electrofocusing in polyacrylamide gel. Of these indoles, indolo[3,2- b]carbazole was the most active. The IC50 value for receptor binding of indolo[3,2-b]carbazole as well as for 2,3,7,8-tetrachlorodibenzofuran was 3.6 nM, whereas that of 5,6-benzoflavone was 26 nM. Both indolo[3,2- b]carbazole and 2,3,7,8-tetrachlorodibenzofuran competitively inhibited the binding of [3H]TCDD to the receptor. The well-known microsomal enzyme inducer 3,3'-diindolymethane did not interact significantly with the TCDD receptor. Previous concepts of structure-activity relationships for binding of chlorinated dioxins to the TCDD receptor fail to account for the receptor binding of unhalogenated aryl hydrocarbon hydroxylase inducers such as 5,6-benzoflavone. We have instead considered the true three-dimensional space occupied by some receptor ligands by means of a computer using crystallographic data as inputs. When the atomic van der Waals radii were included, all potent receptor ligands studied could be fitted into a rectangle of 6.8 X 13.7 A.
This article has been cited by other articles:
|
|
 |
|
  M. J. Anderton, M. M. Manson, R. D. Verschoyle, A. Gescher, J. H. Lamb, P. B. Farmer, W. P. Steward, and M. L. Williams Pharmacokinetics and Tissue Disposition of Indole-3-carbinol and Its Acid Condensation Products after Oral Administration to Mice Clin. Cancer Res., August 1, 2004; 10(15): 5233 - 5241. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Bergander, N. Wahlstrom, T. Alsberg, J. Bergman, A. Rannug, and U. Rannug Characterization of in Vitro Metabolites of the Aryl Hydrocarbon Receptor Ligand 6-Formylindolo[3,2-b]carbazole by Liquid Chromatography-Mass Spectrometry and NMR. Drug Metab. Dispos., February 1, 2003; 31(2): 233 - 241. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Soprano and K. J. Soprano Pharmacological Doses of Some Synthetic Retinoids Can Modulate Both the Aryl Hydrocarbon Receptor and Retinoid Receptor Pathways J. Nutr., January 1, 2003; 133(1): 277S - 281. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Gambone, J. M. Hutcheson, J. L. Gabriel, R. L. Beard, R. A.S. Chandraratna, K. J. Soprano, and D. R. Soprano Unique Property of Some Synthetic Retinoids: Activation of the Aryl Hydrocarbon Receptor Pathway Mol. Pharmacol., February 1, 2002; 61(2): 334 - 342. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. C. Henry, A. S. Kende, G. Rucci, M. J. Totleben, J. J. Willey, S. D. Dertinger, R. S. Pollenz, J. P. Jones, and T. A. Gasiewicz Flavone Antagonists Bind Competitively with 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD) to the Aryl Hydrocarbon Receptor But Inhibit Nuclear Uptake and Transformation Mol. Pharmacol., April 1, 1999; 55(4): 716 - 725. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. A. Miller III Expression of the Human Aryl Hydrocarbon Receptor Complex in Yeast. ACTIVATION OF TRANSCRIPTION BY INDOLE COMPOUNDS J. Biol. Chem., December 26, 1997; 272(52): 32824 - 32829. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-H. Chen, J. Riby, P. Srivastava, J. Bartholomew, M. Denison, and L. Bjeldanes Regulation of CYP1A1 by Indolo[3,2-b]carbazole in Murine Hepatoma Cells J. Biol. Chem., September 22, 1995; 270(38): 22548 - 22555. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
